Physician profile
Scott M Sell
NPI 1134176563
$1,890.12
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $373 · 2021: $620 · 2022: $36.21.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $389.76 | 2019-2021 | |
| Astellas Pharma US INC | $284.07 | 2019-2021 | |
| Pfizer INC. | $136.29 | 2019-2021 | |
| Comsort, INC | $100.00 | 2019 | |
| Dendreon Pharmaceuticals LLC | $93.98 | 2019-2021 | |
| Blue Earth Diagnostics | $68.13 | 2019-2021 | |
| Amgen INC. | $65.05 | 2019-2021 | |
| Antares Pharma, INC. | $64.10 | 2019-2022 | |
| Convatec INC. | $49.41 | 2021 | |
| Allergan, INC. | $48.95 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $45.86 | 2019 | |
| Merck Sharp & Dohme LLC | $43.49 | 2020-2021 | |
| Acerus Pharmaceuticals Corporation | $37.93 | 2020-2021 | |
| Boston Scientific Corporation | $37.17 | 2019-2021 | |
| Olympus America INC. | $34.73 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $32.67 | 2019 | |
| Myriad Genetic Laboratories, INC. | $28.05 | 2021 | |
| Myovant Sciences INC. | $26.52 | 2021 | |
| Urogen Pharma, INC. | $25.16 | 2020 | |
| Neotract INC. | $23.67 | 2019 | |
| Agiliti Surgical, INC. | $23.64 | 2019 | |
| Ambu INC. | $23.22 | 2021 | |
| Alnylam Pharmaceuticals INC. | $21.76 | 2021 | |
| Therapeuticsmd, INC. | $20.51 | 2019 | |
| Coloplast Corp | $17.51 | 2020 | |
| Travere Therapeutics, INC. | $17.45 | 2019 | |
| Sun Pharmaceutical Industries INC. | $17.23 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $17.09 | 2019 | |
| Duchesnay USA Incorporated | $14.81 | 2019 | |
| Karl Storz Lithotripsy-America | $14.63 | 2019 | |
| Rochester Medical Corporation | $14.59 | 2019 | |
| Clarus Therapeutics INC. | $13.79 | 2021 | |
| Endo Pharmaceuticals INC. | $13.69 | 2019 | |
| Mission Pharmacal Company | $13.22 | 2019 | |
| Teleflex LLC | $11.99 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.